NewsNovo
patents give Caring Brands Inc. (Nasdaq: CABR) a defined legal perimeter around its two flagship products as of August 6, 2026.
The read-through for the company's licensing-led model is straightforward: that patent portfolio strengthens the hand in partner negotiations across markets the company sizes at more than $20 billion combined.
What the patents cannot fix is an open Nasdaq delisting proceeding, which places the company's listed status in question at the same moment it is trying to attract global licensees.
A four-plus-one patent structure Four patents cover Hair Enzyme Booster, a topical product designed to work alongside minoxidil by targeting low baseline scalp enzyme levels.
Keep reading